Teamit Research joins VAC4EU, a network focused on the study of vaccines in Europe

Teamit Research has become a member of VAC4EU (Vaccine monitoring Collaboration for Europe), a multi-stakeholder international association with a study network to run studies on vaccine coverage, benefits and risks in Europe to support public health and decision making. The network of research and public health organizations conforms an open community which aims to stimulate scientific discussions and implement continuous methodological developments to support reliable and rapid generation of evidence on vaccines in Europe.

The VAC4EU alliance springs from ADVANCE, a project funded by Innovative Medicines Initiative (IMI) from October 2013- March 2019 and implements its vision, system, and blueprint by enabling robust and timely evidence-generation on the effects of vaccines in a collaborative manner in Europe for use by citizens, health care professionals, public health organisations and regulatory agencies.

Teamit will be able to participate as a study partner managing study implementation and coordinating study operations.

Visit VAC4EU website for more information.